Tetra Bio-Pharma Inc.
TBP
Kedudukan dalam Saham
#35460
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Harga Saham
$0.01851783
Disegerakkan terakhir: 2023-05-23
Modal Pasaran
$3.71M
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
1,443.15%
Negara
CA
Perdagangan Tetra Bio-Pharma Inc. (TBP)
Kategori
Healthcare
Modal pasaran bagi Tetra Bio-Pharma Inc.(TBP)
Modal Pasaran: $3.71M
Sehingga October 2026, Tetra Bio-Pharma Inc. mempunyai modal pasaran sebanyak $3.71M. Ini menjadikan Tetra Bio-Pharma Inc. syarikat ke-35460th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Tetra Bio-Pharma Inc. dari 2011 hingga 2026
TBP berbanding dengan 5 teratas yang paling popular stocks
